Comparison of clinical and laboratory characteristics, initial parameters of the InsulinAPP protocol and follow-up of individuals with type 2 diabetes who used basal-bolus, bolus-correction insulin therapy regimens and that required a change from the bolus-correction to basal-bolus regimen in the first ten days of the protocol. The gene discussed is INS; the disease is type 2 diabetes mellitus.